Following successful meetings from 2016 to 2024, we are delighted to continue this face-to-face meeting for our User Guide to Cancer Immunotherapy Conference in December 2025. Our updated programme will provide an overview of immunotherapy, with a focus on the recognition and management of immune-mediated toxicities. The meeting will have a strong clinical emphasis, aimed at providing delegates with practical guidance that can be used in daily practice. As such, it will be of value to healthcare professionals involved in the delivery of cancer care including doctors, nurses, pharmacists and physician associates working in oncology, acute medicine, emergency medicine, medical specialties and general practice. We look forward to seeing you in December 2025.
